

Pamir Ventures: JPM’26 Builders & Backers Breakfast
🌟 Kick off JPM on Tuesday with the brightest minds shaping the future of AI and Bio
Join Pamir Ventures for an exclusive CEO & Investor Breakfast. Located high above the Embarcadero at the Norton Rose Fulbright offices, we offer a quiet vantage point to connect before the frenzy of the day begins.
While this marks Pamir Ventures’ inaugural JPM breakfast, the spirit of the event will be familiar to many. It continues a tradition of high-signal community building that our General Partner, Milad Alucozai, has championed for years—bringing that same commitment to thoughtful connection with his new fund.
This gathering is an intersection of innovation and capital. We are convening a curated group of founders and funders who are actively shaping the future of AI and Bio for a morning of meaningful interactions.
The Experience:
🤝 High-Caliber Networking: A room reserved for healthcare & AI leaders, devoid of sales pitches.
☕ Fuel for the Day: An elevated breakfast experience in a warm, sophisticated atmosphere.
🔗 Real Connection: A space explicitly designed for deep conversation, not surface-level mingling.
Event Details:
📅 Date: Tuesday, January 13, 2025
⏰ Time: 9:00 – 11:30 AM
📍 Venue: One Embarcadero Center, San Francisco
A note to guests:
We are limited on space and will not be able to accommodate walk-ins. Only accepted RSVPs.
By registering for this event, you hereby agree to the Code of Conduct and Media Release.
Excited to see you there — and yes, selfies encouraged 😊
Milad + Anand + Jason + Raymond
The Pamir Ventures + Norton Rose Fulbright + Twill Team
⭐ Speaker Spotlight: Milad Alucozai
Recognized by Business Insider as a Top 100 Early-Stage Investor, Milad Alucozai is a neuroscientist, founder, and ecosystem builder bridging scientific discovery and commercialization across the US, Canada, and the UK. He is a General Partner at Pamir Ventures and Co-founder of Revalia Bio. He has made over 100 investments and facilitated more than $1 billion in co-development partnerships. Milad mentors scientist-entrepreneurs through Creative Destruction Lab and served as an Expert-in-Residence for ARPA-H, where he supported the deployment of $1.5 billion in non-dilutive funding for transformative biomedical breakthroughs.